{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:22:54Z","timestamp":1788906174664,"version":"build-2803163510"},"reference-count":71,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T00:00:00Z","timestamp":1384300800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0079421","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T23:07:18Z","timestamp":1384384038000},"page":"e79421","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Comparisons of the Efficacy of Alpha Glucosidase Inhibitors on Type 2 Diabetes Patients between Asian and Caucasian"],"prefix":"10.1371","volume":"8","author":[{"given":"Xiaoling","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueyao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,11,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"928","DOI":"10.7326\/0003-4819-121-12-199412150-00004","article-title":"The efficacy of acarbose in the treatment of patients with NIDDM: a multicenter controlled clinical trial","volume":"121","author":"JL Chiasson","year":"1994","journal-title":"Ann Intern Med"},{"key":"ref2","first-page":"132","article-title":"\u03b1-Glucosidase inhibitors as agents in the treatment of diabetes","volume":"(2)","author":"HE Lebovitz","year":"1998","journal-title":"Diabetes Rev 6"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00044011-200222030-00001","article-title":"Acarbose: an update of its therapeutic use in diabetes treatment","volume":"(3)","author":"H Laube","year":"2002","journal-title":"Clin Drug Invest 22"},{"key":"ref4","first-page":"3","article-title":"Dietary pattern analysis: a new direction in nutritional epidemiology. Curr Opin Lipidol","volume":"13","author":"FB Hu","year":"2002"},{"key":"ref5","unstructured":"Food and Agriculture Organization of the United Nations (2013) Dimensions of need- Staple foods: what do people eat? <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.fao.org\/docrep\/u8480e\/u8480e07.htm\" xlink:type=\"simple\">http:\/\/www.fao.org\/docrep\/u8480e\/u8480e07.htm<\/ext-link>."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2337\/diacare.28.1.154","article-title":"\u03b1-Glucosidase Inhibitors for Patients With Type 2 Diabetes. Results from a Cochrane systematic review and meta-analysis","volume":"28","author":"FA Van De Laar","year":"2005","journal-title":"Diabetes Care"},{"key":"ref7","first-page":"1221","article-title":"Efficacy and Safety Profile Evaluation of Acarbose Alone and in Association With Other Antidiabetic Drugs: A Systematic Review Clin Ther","volume":"34","author":"G Derosa","year":"2012"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of randomized controlled trials: is blinding necessary?","volume":"17","author":"AR Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jama.2009.1242","article-title":"Comparison of Registered and Published Primary Outcomes in Randomized Controlled Trials","volume":"302(9)","author":"S Mathieu","year":"2009","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2337\/diacare.21.7.1058","article-title":"An Asian multicenter clinical trial to assess the efficacy and tolerability of acarbose compared with placebo in type 2 diabetic patients previously treated with diet. Asian Acarbose Study Group","volume":"21(7)","author":"JC Chan","year":"1998","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1464-5491.1993.tb00030.x","article-title":"Long-term effect of acarbose on glycaemic control in non-insulin-dependent diabetes mellitus: a placebo-controlled double-blind study","volume":"10(2)","author":"N Hotta","year":"1993","journal-title":"Diabet Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2337\/diacare.25.4.658","article-title":"Effects of Dietary Treatment Alone or Diet With Voglibose or Glyburide on Abdominal Adipose Tissue and Metabolic Abnormalities in Patients With Newly Diagnosed Type 2 Diabetes","volume":"25","author":"K Takami","year":"2002","journal-title":"Diabetes Care"},{"key":"ref13","first-page":"1610","article-title":"Impact of Acarbose on Carotid Intima-Media Thickness in Patients With Newly Diagnosed Impaired Glucose Tolerance or Mild Type 2 Diabetes Mellitus: A One-Year, Prospective, Randomized, Open-Label, Parallel-Group Study in Japanese Adults With Established Coronary Artery Disease.Clin Ther","volume":"32","author":"M Koyasu","year":"2010"},{"key":"ref14","first-page":"12","article-title":"A Prospective, Parallel Group, Open-Labeled, Comparative, Multi-centric, Active Study to Evaluate the Safety, Tolerability and Benefits of Fixed Dose Combination o and Metformin versus Metformin Alone in Type 2 Diabetes","volume":"58","author":"S Jayaram","year":"2010","journal-title":"Journal of Association Physicians of India"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1440-1681.2010.05361.x","article-title":"Glipizide controlled-release tablets, with or without acarbose, improve glycaemic variability in newly diagnosed Type 2 diabetes","volume":"37","author":"YQ Bao","year":"2010","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0168-8227(03)00015-9","article-title":"The Asian Acarbose Study Group. Acarbose improves glycemic control in insulin-treated Asian type 2 diabetic patients: Results from a multinational, placebocontrolled study","volume":"60","author":"CM Hwu","year":"2003","journal-title":"Diabetes Research and Clinical Practice"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S1056-8727(02)00258-1","article-title":"The Writing Group for the Asian Study of Acarbose with Sulfonylureas. Efficacy and tolerability of acarbose in Asian patients with type 2 diabetes inadequately controlled with diet and sulfonylureas","volume":"17","author":"BJ Lin","year":"2003","journal-title":"Journal of Diabetes and Its Complications"},{"key":"ref18","first-page":"1154","article-title":"Acarbose in NIDDM Patients With Poor Control on Conventional Oral Agents. A 24-week placebo-controlled study","volume":"21(7)","author":"KSL Lam","year":"1998","journal-title":"Dabetes Care"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5551\/jat.E549","article-title":"Effect of acarbose, an alpha-glucosidase inhibitor, or serum lipoprotein lipase mass levels and common carotid artery intima-media thickness in type 2 diabetes mellitus treated by sulfonylurea","volume":"15","author":"T Oyama","year":"2008","journal-title":"Journal of atherosclerosis and thrombosis"},{"key":"ref20","first-page":"71","article-title":"Evaluation of the efficacy and tolerability of miglitol in Chinesepatients with type 2 diabetes mellitus inadequately controlled by diet and sulfonylureas","volume":"48","author":"SH Hsieh","year":"2011","journal-title":"ActaDiabetol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00592-010-0206-4","article-title":"Efficacy of combined use of miglitol in Type 2 diabetes patients receiving insulin therapy-placebo-controlled double-blind comparative study","volume":"48","author":"M Nemoto","year":"2011","journal-title":"Acta Diabetol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1475-2840-9-12","article-title":"Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study","volume":"9","author":"T Kato","year":"2010","journal-title":"Cardiovascular Diabetology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.metabol.2007.06.010","article-title":"Miglitol increases the adiponectin level and decreases urinary albumin excretion in patients with type 2 diabetes mellitus","volume":"56","author":"H Yokoyama","year":"2007","journal-title":"Metabolism Clinical and Experimental"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1463-1326.2011.01545.x","article-title":"Linagliptinmonotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study","volume":"14","author":"R Kawamori","year":"2012","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref25","unstructured":"Pan C, Yang W, Barona JP, Wang Y, Niggli M, <etal>et al<\/etal>. (2008) Comparison of vildagliptin and acarbosemonotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial. Diabet. Med 25, 435\u2013441."},{"key":"ref26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1463-1326.2010.01197.x","article-title":"Efficacy and safety of sitagliptinmonotherapy compared with voglibose in Japanese patients with type 2 diabetes: a randomized, double-blind trial","volume":"12","author":"Y Iwamoto","year":"2010","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref27","first-page":"1932","article-title":"Effects of Acarbose Versus Glibenclamide on Glycemic Excursion and Oxidative Stress in Type 2 Diabetic Patients Inadequately Controlled by Metformin: A 24-Week, Randomized, Open-Label, Parallel-Group Comparison","volume":"33","author":"JS Wang","year":"2011","journal-title":"ClinTher"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jdiacomp.2011.06.004","article-title":"The beneficial effect of \u03b1-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data","volume":"25","author":"SD Lin","year":"2011","journal-title":"Journal of Diabetes and Its Complications"},{"key":"ref29","first-page":"201","article-title":"Influence of 16-week monotherapy with acarbose on cardiovascular risk factors in obese subjects with non-insulin-dependent DM: a controlled, double-blind comparison study with placebo","volume":"22","author":"A Calle-Pascuac","year":"1996","journal-title":"Diabetes & Metabolism"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jdiacomp.2011.01.003","article-title":"Acarbose on insulin resistance after an oral fat load: a double-blind, placebo controlled study","volume":"25","author":"G Derosa","year":"2011","journal-title":"Journal of Diabetes and Its Complications"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"928","DOI":"10.7326\/0003-4819-121-12-199412150-00004","article-title":"The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus: a multicenter, controlled clinical trial","volume":"121","author":"JL Chiasson","year":"1994","journal-title":"Ann Intern Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/diacare.24.6.989","article-title":"The Synergistic Effect of Miglitol Plus Metformin Combination Therapy in the Treatment of Type 2 Diabetes","volume":"24","author":"JL Chiasson","year":"2001","journal-title":"Diabetes Care"},{"key":"ref33","first-page":"195","article-title":"Acarbose improves indirectly both insulin resistance and secretion in obese type 2 diabetic patients","volume":"28","author":"H Delgado","year":"2002","journal-title":"Diabetes Metab"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1463-1326.2001.00103.x","article-title":"Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis","volume":"3","author":"S Gentile","year":"2001","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0168-8227(01)00347-3","article-title":"Different effects of acarbose and glibenclamide on proinsulin and insulin profiles in people with Type 2 diabetes","volume":"55","author":"M Hanefeld","year":"2002","journal-title":"Diabetes Research and Clinical Practice"},{"key":"ref36","first-page":"132","article-title":"Effect of Acarbose on Postmeal Mononuclear Blood Cell Response in Patients with Early Type 2 Diabetes: The AI(I)DA Study","volume":"41","author":"M Hanefeld","year":"2009","journal-title":"HormMetab Res"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9343(97)00252-0","article-title":"Efficacy of 24-Week Monotherapy with Acarbose, Metformin, or Placebo in Dietary-treated NIDDM Patients: The Essen-II Study","volume":"103","author":"J Hoffmann","year":"1997","journal-title":"Am J Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2337\/diacare.17.6.561","article-title":"Efficacy of 24-Week Monotnerapy With Acarbose, Ghbenclamide, or Placebo in NIDDM Patients. The Essen Study","volume":"17(6)","author":"J Hoffmann","year":"1994","journal-title":"Diabetes Care"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.2337\/dc06-0061","article-title":"Treating Postprandial Hyperglycemia Does Not Appear to Delay Progression of Early Type 2 Diabetes. The Early Diabetes Intervention Program","volume":"29","author":"MS Kirkman","year":"2006","journal-title":"Diabetes Care"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.2337\/diacare.23.8.1162","article-title":"Effect of Acarbose on Insulin Sensitivity in Elderly Patients With Diabetes","volume":"23","author":"GS Meneilly","year":"2000","journal-title":"Diabetes Care"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1590\/S0100-879X2002000800004","article-title":"Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters","volume":"35","author":"P Rosenbaum","year":"2002","journal-title":"Brazilian journal of medical and biological Research"},{"key":"ref42","doi-asserted-by":"crossref","DOI":"10.1016\/0168-8227(95)01081-N","article-title":"Acarbose for the treatment of Type II diabetes: the results of a Canadian multi-centre trial","volume":"28","author":"RG Josse","year":"1995","journal-title":"Diabetes Research and Clinical Practice"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-8227(02)00176-6","article-title":"Acarbose in the treatment of elderly patients with type 2 Diabetes","volume":"59","author":"RG Josse","year":"2003","journal-title":"Diabetes Research and Clinical Practice"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8227(99)00009-1","article-title":"Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus?","volume":"43","author":"R Scott","year":"1999","journal-title":"Diabetes Research and Clinical Practice"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2337\/dc05-2513","article-title":"Combined Treatment With Exercise Training and Acarbose Improves Metabolic Control and Cardiovascular Risk Factor Profile in Subjects With Mild Type 2 Diabetes","volume":"29","author":"H Wagner","year":"2006","journal-title":"Diabetes Care"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/diacare.20.5.687","article-title":"The Efficacy and Safely of Miglitol Therapy Compared With Glibenclamide in Patients With NIDDM Inadequately Controlled by Diet Alone","volume":"20(5)","author":"P Segal","year":"1997","journal-title":"Diabetes Care"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/diacare.21.3.416","article-title":"Chronic Treatment of African-American Type 2 Diabetic Patients With a-Glucosidase Inhibition","volume":"21(3)","author":"PS Johnson","year":"1998","journal-title":"Diabetes Care"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2337\/diacare.21.3.409","article-title":"Long-Term Titrated-Dose a-Glucosidase Inhibition in Non-Insulin-Requiring Hispanic NIDDM Patients","volume":"21(3)","author":"PS Johnson","year":"1998","journal-title":"Diabetes Care"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2165\/00044011-200323100-00007","article-title":"Long-Term Improvement of Metabolic Control by Acarbose in Type 2 Diabetes Patients Poorly Controlled with Maximum Sulfonylurea Therapy","volume":"(10)","author":"W Bachmann","year":"2003","journal-title":"Clin Drug Invest 23"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0168-8227(00)00163-7","article-title":"Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with Type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study","volume":"50","author":"S Halimi","year":"2000","journal-title":"Diabetes Research and Clinical Practice"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.2337\/diacare.21.12.2056","article-title":"Efficacy and Safety of Acarbose in Insulin-teated Patients With Type 2 Diabetes","volume":"21","author":"DE Kelley","year":"1998","journal-title":"Diabetes Care"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2337\/diacare.26.2.269","article-title":"Acarbose Improves Glycemic Control in Overweight Type 2 Diabetic Patients Insufficiently Treated With Metformin","volume":"26","author":"P Phillips","year":"2003","journal-title":"Diabetes Care"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.2337\/diacare.21.12.2050","article-title":"Efficacy and Safety of Acarbose in Metformin-Treated Patients With Type 2 Diabetes","volume":"21","author":"J Rosenstock","year":"1998","journal-title":"Diabetes Care"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1463-1326.2006.00666.x","article-title":"Acarbose and metabolic control in patients with type 2 diabetes with newly initiated insulin therapy","volume":"9","author":"O Schnell","year":"2007","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1463-1326.1999.00021.x","article-title":"Effect of acarbose on additional insulin therapy in type 2 diabetic patients with late failure of sulphonylurea therapy","volume":"1","author":"E Standl","year":"1999","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0168-8227(00)00231-X","article-title":"Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics","volume":"52","author":"E Standl","year":"2001","journal-title":"Diabetes Research and Clinical Practice"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1046\/j.1464-5491.1999.00149.x","article-title":"Comparison of acarbose and metformin in patients with type 2 diabetes mellitus insufficiently controlled with diet and sulphonylureas: a randomized, placebo-controlled study","volume":"16","author":"B Willms","year":"1999","journal-title":"Diabetic Medicine"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00592-007-0004-9","article-title":"Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes","volume":"44","author":"H Yilmaz","year":"2007","journal-title":"Acta Diabetol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1463-1326.2001.00141.x","article-title":"Miglitol combined with metformin improves glycaemic control in type 2 diabetes","volume":"3","author":"L Van Gaal","year":"2001","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"ref60","first-page":"657","article-title":"Long-term Effectiveness of a New a-Glucosidase Inhibitor (BAY m1099-Miglitol) in Insulin-treated Type 2 Diabetes Mellitus. Diabet","volume":"15","author":"A Mitrakou","year":"1998","journal-title":"Med"},{"key":"ref61","first-page":"214","article-title":"Prospective multicentre trial comparing the efficacy of, and compliance with, glimepiride or acarbose treatment in patients with type 2 diabetes not controlled with diet alone","volume":"16(4)","author":"C Feinb\u00f6ck","year":"2003","journal-title":"Diabetes Nutr Metab"},{"key":"ref62","first-page":"329","article-title":"Improved Glycemic Control and Lipid Profile in a Randomized Study of Pioglitazone Compared with Acarbose in Patients with Type 2 Diabetes Mellitus","volume":"1(5)","author":"B G\u00f6ke","year":"2002","journal-title":"Treat Endocrinol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1185\/030079901750120231","article-title":"Comparison of Acarbose and Gliclazide as First-line Agents in Patients with Type 2 Diabetes","volume":"16(4)","author":"S Salman","year":"2001","journal-title":"Current Medical Research and Opinion"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2337\/diacare.19.3.252","article-title":"A comparison of acarbose versus metformin as an adjuvant therapy in sulfonylurea-treated NIDDM patients","volume":"19(3)","author":"M Bayraktar","year":"1996","journal-title":"Diabetes Care"},{"key":"ref65","first-page":"723e733","article-title":"Modulation of adipokines and vascular remodelling markers during OGTT with acarbose or pioglitazone treatment","volume":"63","author":"Derosa Giuseppe","year":"2009","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2710.2009.01132.x","article-title":"Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin","volume":"35","author":"G Derosa","year":"2010","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF03345682","article-title":"The investigation of the efficacy of insulin glargine on glycemic control when combined with either repaglinide or acarbose in obese type 2 diabetic patients","volume":"32","author":"C Duran","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s005920050151","article-title":"Effects of combination of insulin and acarbose compared with insulin and gliclazide in type 2 diabetic patients","volume":"36","author":"N G\u00fcvener","year":"1999","journal-title":"Acta Diabetol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.clinthera.2013.03.020","article-title":"Comparison of the Hypoglycemic Effect of Acarbose Monotherapy in Patients With Type 2 Diabetes Mellitus Consuming an Eastern or Western Diet: A Systematic Meta-analysis","volume":"35(6)","author":"Q Zhu","year":"2013","journal-title":"Clinical Therapeutics"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1463-1326.2003.00239.x","article-title":"Influence of treatment with acarbose or glibenclamide on insulin sensitivity in type 2 diabetic patients","volume":"5","author":"S Fischer","year":"2003","journal-title":"Diabetes Obesity and Metabolsim"},{"key":"ref71","first-page":"277","article-title":"Effects of acarbose treatment in type 2 diabetic patients under dietary training: A multicenter, double-blind, placebo-controlled, 2 year study","volume":"12","author":"H Hasche","year":"1999","journal-title":"Diab Nutr Metab"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0079421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T07:29:01Z","timestamp":1647070141000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0079421"}},"subtitle":[],"editor":[{"given":"Noel Christopher","family":"Barengo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,11,13]]},"references-count":71,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0079421","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,13]]}}}